Literature DB >> 19789903

Total synthesis and antileishmanial activity of the natural occurring acetylenic fatty acids 6-heptadecynoic acid and 6-icosynoic acid.

Néstor M Carballeira1, Michelle M Cartagena, Christopher Fernández Prada, Celia Fernández Rubio, Rafael Balaña-Fouce.   

Abstract

The first total syntheses of the naturally occurring acetylenic fatty acids-6-heptadecynoic acid (59% overall yield) and 6-icosynoic acid (34% overall yield)-was accomplished in four steps. Using the same synthetic sequence the naturally occurring fatty acids (6Z)-heptadecenoic acid (46% overall yield) and (6Z)-icosenoic acid (27% overall yield) were also synthesized. The Delta(6) acetylenic fatty acids displayed good antiprotozoal activity towards Leishmania donovani promastigotes (EC(50) = 1-6 microg/mL), but the 6-icosynoic acid was the most effective in the series. In addition, the (6Z)-icosenoic acid was a much better antiprotozoal compound (EC(50) = 5-6 microg/mL) than the (6Z)-heptadecenoic acid (EC(50) > 25 microg/mL). The saturated fatty acids n-heptadecanoic acid and n-eicosanoic acid were not effective towards L. donovani, indicating that the Delta(6) unsaturation in these fatty acids is necessary for leishmanicidal activity. In addition, both the 6-icosynoic acid and the (6Z)-icosenoic acid were inhibitors of the Leishmania DNA topoisomerase IB enzyme (EC(50's) = 36-49 microM), a possible intracellular target for these compounds. This is the first study assessing fatty acids as inhibitors of the Leishmania DNA topoisomerase IB enzyme.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19789903      PMCID: PMC2899701          DOI: 10.1007/s11745-009-3345-z

Source DB:  PubMed          Journal:  Lipids        ISSN: 0024-4201            Impact factor:   1.880


  15 in total

Review 1.  Miltefosine to treat leishmaniasis.

Authors:  Jonathan Berman
Journal:  Expert Opin Pharmacother       Date:  2005-07       Impact factor: 3.889

2.  Effect of long-chain fatty acids on some trypanosomatid flagellates.

Authors:  L V Cunningham; B H Kazan; S S Kuwahara
Journal:  J Gen Microbiol       Date:  1972-05

3.  Two novel iso-branched octadecenoic acids from a Micrococcus species.

Authors:  N M Carballeira; M Pagán; F Shalabi; J T Nechev; K Lahtchev; A Ivanova; K Stefanov
Journal:  J Nat Prod       Date:  2000-11       Impact factor: 4.050

4.  Potent in vitro antifungal activities of naturally occurring acetylenic acids.

Authors:  Xing-Cong Li; Melissa R Jacob; Shabana I Khan; M Khalid Ashfaq; K Suresh Babu; Ameeta K Agarwal; Hala N Elsohly; Susan P Manly; Alice M Clark
Journal:  Antimicrob Agents Chemother       Date:  2008-05-05       Impact factor: 5.191

5.  A novel active DNA topoisomerase I in Leishmania donovani.

Authors:  Héctor Villa; Ana R Otero Marcos; Rosa M Reguera; Rafael Balaña-Fouce; Carlos García-Estrada; Yolanda Pérez-Pertejo; Babu L Tekwani; Peter J Myler; Kenneth D Stuart; Mary-Ann Bjornsti; David Ordóñez
Journal:  J Biol Chem       Date:  2002-11-19       Impact factor: 5.157

Review 6.  Paromomycin in the treatment of leishmaniasis.

Authors:  Shyam Sundar; Jaya Chakravarty
Journal:  Expert Opin Investig Drugs       Date:  2008-05       Impact factor: 6.206

Review 7.  Leishmaniasis: current situation and new perspectives.

Authors:  P Desjeux
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268

8.  Phase 4 trial of miltefosine for the treatment of Indian visceral leishmaniasis.

Authors:  Sujit Kumar Bhattacharya; Prabhat Kumar Sinha; Shyam Sundar; Chandreshar Prasad Thakur; Tara Kant Jha; Krishna Pandey; Vidyanand Rabi Das; Naveen Kumar; Chandrasekhar Lal; Neena Verma; Vijay Pratap Singh; Alok Ranjan; Rakesh Bihari Verma; Gerlind Anders; Herbert Sindermann; Nirmal Kumar Ganguly
Journal:  J Infect Dis       Date:  2007-06-29       Impact factor: 5.226

Review 9.  Treatment of visceral leishmaniasis: a review of current treatment practices.

Authors:  Pierre Marty; Eric Rosenthal
Journal:  Expert Opin Pharmacother       Date:  2002-08       Impact factor: 3.889

10.  Mutational study of the "catalytic tetrad" of DNA topoisomerase IB from the hemoflagellate Leishmania donovani: Role of Asp-353 and Asn-221 in camptothecin resistance.

Authors:  Rosario Diaz-González; Yolanda Pérez-Pertejo; Yves Pommier; Rafael Balaña-Fouce; Rosa M Reguera
Journal:  Biochem Pharmacol       Date:  2008-07-04       Impact factor: 6.100

View more
  10 in total

1.  2-Hexadecynoic acid inhibits plasmodial FAS-II enzymes and arrests erythrocytic and liver stage Plasmodium infections.

Authors:  Deniz Tasdemir; David Sanabria; Ina L Lauinger; Alice Tarun; Rob Herman; Remo Perozzo; Mire Zloh; Stefan H Kappe; Reto Brun; Néstor M Carballeira
Journal:  Bioorg Med Chem       Date:  2010-09-18       Impact factor: 3.641

2.  First Total Synthesis of ω-Phenyl Δ6 Fatty Acids and their Leishmanicidal and Anticancer Properties.

Authors:  Nestor M Carballeira; Christian Morales-Guzman; Ester Alvarez-Benedicto; Zally Torres-Martinez; Yamixa Delgado; Kai H Griebenow; Arthur D Tinoco; Rosa M Reguera; Yolanda Perez-Pertejo; Ruben Carbajo-Andres; Rafael Balana-Fouce
Journal:  Curr Top Med Chem       Date:  2018       Impact factor: 3.295

3.  First total synthesis of the (±)-2-methoxy-6-heptadecynoic acid and related 2-methoxylated analogs as effective inhibitors of the leishmania topoisomerase IB enzyme.

Authors:  Néstor M Carballeira; Michelle Cartagena; Fengyu Li; Zhongfang Chen; Christopher F Prada; Estefania Calvo-Alvarez; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Pure Appl Chem       Date:  2012-04-29       Impact factor: 2.453

Review 4.  Recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids.

Authors:  Néstor M Carballeira
Journal:  Chem Phys Lipids       Date:  2013-05-28       Impact factor: 3.329

5.  Synthesis of the novel (±)-2-methoxy-6-icosynoic acid--a fatty acid that induces death of neuroblastoma cells.

Authors:  Elsie A Orellano; Michelle M Cartagena; Karolyna Rosado; Néstor M Carballeira
Journal:  Chem Phys Lipids       Date:  2013-05-03       Impact factor: 3.329

6.  The (5Z)-5-Pentacosenoic and 5-Pentacosynoic Acids Inhibit the HIV-1 Reverse Transcriptase.

Authors:  Lizabeth Giménez Moreira; Elsie A Orellano; Karolyna Rosado; Rafael V C Guido; Adriano D Andricopulo; Gabriela Ortiz Soto; José W Rodríguez; David J Sanabria-Ríos; Néstor M Carballeira
Journal:  Lipids       Date:  2015-09-07       Impact factor: 1.880

7.  Apoptosis mediated leishmanicidal activity of Azadirachta indica bioactive fractions is accompanied by Th1 immunostimulatory potential and therapeutic cure in vivo.

Authors:  Garima Chouhan; Mohammad Islamuddin; Muzamil Y Want; Malik Z Abdin; Hani A Ozbak; Hassan A Hemeg; Dinkar Sahal; Farhat Afrin
Journal:  Parasit Vectors       Date:  2015-03-26       Impact factor: 3.876

Review 8.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

9.  Arrabidaea chica hexanic extract induces mitochondrion damage and peptidase inhibition on Leishmania spp.

Authors:  Igor A Rodrigues; Mariana M B Azevedo; Francisco C M Chaves; Celuta S Alviano; Daniela S Alviano; Alane B Vermelho
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

Review 10.  Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.

Authors:  María Álvarez-Bardón; Yolanda Pérez-Pertejo; César Ordóñez; Daniel Sepúlveda-Crespo; Nestor M Carballeira; Babu L Tekwani; Sankaranarayanan Murugesan; Maria Martinez-Valladares; Carlos García-Estrada; Rosa M Reguera; Rafael Balaña-Fouce
Journal:  Mar Drugs       Date:  2020-03-31       Impact factor: 5.118

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.